The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.
Article Details
- CitationCopy to clipboard
Paugh SW, Payne SG, Barbour SE, Milstien S, Spiegel S
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.
FEBS Lett. 2003 Nov 6;554(1-2):189-93. doi: 10.1016/s0014-5793(03)01168-2.
- PubMed ID
- 14596938 [ View in PubMed]
- Abstract
The potent immunosuppressive drug FTY720, a sphingosine analog, induces redistribution of lymphocytes from circulation to secondary lymphoid tissues. FTY720 is phosphorylated in vivo and functions as an agonist for four G-protein-coupled sphingosine-1-phosphate receptors. The identity of the kinase that phosphorylates FTY720 is still not known. Here we report that although both sphingosine kinase type 1 (SphK1) and type 2 (SphK2) can phosphorylate FTY720 with low efficiency, SphK2 is much more effective than SphK1. FTY720 inhibited phosphorylation of sphingosine catalyzed by SphK2 to a greater extent than it inhibits SphK1. Thus, SphK2 may be the relevant enzyme that is responsible for in vivo phosphorylation of FTY720.
DrugBank Data that Cites this Article
- Drug Enzymes
Drug Enzyme Kind Organism Pharmacological Action Actions Fingolimod Sphingosine kinase 1 Protein Humans UnknownSubstrateInhibitorDetails